These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 37184839

  • 1. Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial.
    Rastogi A, Kulkarni SA, Agarwal S, Akhtar M, Arsule S, Bhamre S, Bhosle D, Desai S, Deshmukh M, Giriraja KV, Jagannath J, Kashiva RY, Kesavan R, Khandelwal D, Kolte S, Kongara S, Darivemula AK, Madhusudan C, Pyare Saheb Qureshi MAH, Ramu M, Rathod G, Yalamanchi SR, Shakya S, Shetty P, Singh S, Deshpande SK, Viswanathan V, Unnikrishnan AG.
    JAMA Netw Open; 2023 May 01; 6(5):e2311509. PubMed ID: 37184839
    [Abstract] [Full Text] [Related]

  • 2. Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial.
    Huang YY, Lin CW, Cheng NC, Cazzell SM, Chen HH, Huang KF, Tung KY, Huang HL, Lin PY, Perng CK, Shi B, Liu C, Ma Y, Cao Y, Li Y, Xue Y, Yan L, Li Q, Ning G, Chang SC.
    JAMA Netw Open; 2021 Sep 01; 4(9):e2122607. PubMed ID: 34477854
    [Abstract] [Full Text] [Related]

  • 3. Novel Topical Esmolol Hydrochloride (Galnobax) for Diabetic Foot Wound: Phase 1/2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Parallel-Group Study.
    Rastogi A, Kulkarni SA, Deshpande SK, Driver V, Barman H, Bal A, Deshmukh M, Nair H.
    Adv Wound Care (New Rochelle); 2023 Aug 01; 12(8):429-439. PubMed ID: 36245145
    [Abstract] [Full Text] [Related]

  • 4. Topical Erythropoietin Accelerates Wound Closure in Patients with Diabetic Foot Ulcers: A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial.
    Hamed S, Ullmann Y, Belokopytov M, Shoufani A, Kabha H, Masri S, Feldbrin Z, Kogan L, Kruchevsky D, Najjar R, Liu PY, Kerihuel JC, Akita S, Teot L.
    Rejuvenation Res; 2021 Aug 01; 24(4):251-261. PubMed ID: 33504262
    [Abstract] [Full Text] [Related]

  • 5. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
    Kaur R, Tchanque-Fossuo C, West K, Hadian Y, Gallegos A, Yoon D, Ismailyan L, Schaefer S, Dahle SE, Isseroff RR.
    Trials; 2020 Jun 08; 21(1):496. PubMed ID: 32513257
    [Abstract] [Full Text] [Related]

  • 6. A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study.
    Frykberg RG, Franks PJ, Edmonds M, Brantley JN, Téot L, Wild T, Garoufalis MG, Lee AM, Thompson JA, Reach G, Dove CR, Lachgar K, Grotemeyer D, Renton SC, TWO2 Study Group.
    Diabetes Care; 2020 Mar 08; 43(3):616-624. PubMed ID: 31619393
    [Abstract] [Full Text] [Related]

  • 7. A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.
    Snyder RJ, Shimozaki K, Tallis A, Kerzner M, Reyzelman A, Lintzeris D, Bell D, Rutan RL, Rosenblum B.
    Wounds; 2016 Mar 08; 28(3):70-7. PubMed ID: 26978860
    [Abstract] [Full Text] [Related]

  • 8. A multicenter clinical trial evaluating the durability of diabetic foot ulcer healing in ulcers treated with topical oxygen and standard of care versus standard of care alone 1 year post healing.
    Al-Jalodi O, Kupcella M, Breisinger K, Serena TE.
    Int Wound J; 2022 Nov 08; 19(7):1838-1842. PubMed ID: 35437881
    [Abstract] [Full Text] [Related]

  • 9. A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
    Armstrong DG, Orgill DP, Galiano RD, Glat PM, Kaufman JP, Carter MJ, DiDomenico LA, Zelen CM.
    Int Wound J; 2024 Apr 08; 21(4):e14882. PubMed ID: 38606794
    [Abstract] [Full Text] [Related]

  • 10. Interim Results of the Remede d'Or Study: A Multicenter, Single-Blind, Randomized, Controlled Trial to Assess the Safety and Efficacy of an Innovative Topical Formulation of Erythropoietin for Treating Diabetic Foot Ulcers.
    Hamed S, Belokopytov M, Ullmann Y, Safadi M, Stark Y, Shoufani A, Akita S, Liu PY, Teot L.
    Adv Wound Care (New Rochelle); 2019 Oct 01; 8(10):514-521. PubMed ID: 31832270
    [Abstract] [Full Text] [Related]

  • 11. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial.
    Serena TE, Bullock NM, Cole W, Lantis J, Li L, Moore S, Patel K, Sabo M, Wahab N, Price P.
    J Wound Care; 2021 May 01; 30(Sup5):S7-S14. PubMed ID: 33979229
    [Abstract] [Full Text] [Related]

  • 12. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR, Reyzelman A, Kawalec J, French M.
    Ostomy Wound Manage; 2017 Apr 01; 63(4):12-28. PubMed ID: 28448266
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective.
    Su HY, Yang CY, Ou HT, Chen SG, Chen JC, Ho HJ, Kuo S.
    JAMA Netw Open; 2023 Jan 03; 6(1):e2250639. PubMed ID: 36633847
    [Abstract] [Full Text] [Related]

  • 14. Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial.
    Cazzell SM, Caporusso J, Vayser D, Davis RD, Alvarez OM, Sabolinski ML.
    J Wound Care; 2024 Jul 01; 33(Sup7):S4-S14. PubMed ID: 38973638
    [Abstract] [Full Text] [Related]

  • 15. Effect of electrospun poly (L-lactide-co-caprolactone) and formulated porcine fibrinogen for diabetic foot ulcers.
    Wang G, Li X, Ju S, Li Y, Li W, He H, Cai Y, Dong Z, Fu W.
    Eur J Pharm Sci; 2024 Jul 01; 198():106800. PubMed ID: 38754593
    [Abstract] [Full Text] [Related]

  • 16. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M, Uzun G, Bennett M, Germonpré P, Smart D, Mathieu D.
    Diving Hyperb Med; 2016 Sep 01; 46(3):133-134. PubMed ID: 27723012
    [Abstract] [Full Text] [Related]

  • 17. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
    Buzzi M, de Freitas F, Winter M.
    Ostomy Wound Manage; 2016 Mar 01; 62(3):8-24. PubMed ID: 26978856
    [Abstract] [Full Text] [Related]

  • 18. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM, Orgill DP, Serena T, Galiano R, Carter MJ, DiDomenico LA, Keller J, Kaufman J, Li WW.
    Int Wound J; 2017 Apr 01; 14(2):307-315. PubMed ID: 27073000
    [Abstract] [Full Text] [Related]

  • 19. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA, Orgill DP, Galiano RD, Serena TE, Carter MJ, Kaufman JP, Young NJ, Jacobs AM, Zelen CM.
    Int Wound J; 2018 Dec 01; 15(6):950-957. PubMed ID: 30019528
    [Abstract] [Full Text] [Related]

  • 20. Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.
    Grek CL, Prasad GM, Viswanathan V, Armstrong DG, Gourdie RG, Ghatnekar GS.
    Wound Repair Regen; 2015 Dec 01; 23(2):203-12. PubMed ID: 25703647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.